NFKB1 and inflammatory bowel disease: Furthermore, in inflammatory bowel disease, INAVA was used for mitogen-activated protein kinase (MAPK), nuclear factor kappa-B (NF-κB) activation, cytokine secretion, and intracellular bacterial clearance after pattern recognition receptor (PRR) stimulation (Yan et al., 2017).